Dr. Nancy Carnide
Dr. Nancy Carnide is an associate scientist at the Institute for Work & Health.
She has a PhD in epidemiology from the Dalla Lana School of Public Health at the University of Toronto. During her PhD, she was the recipient of a Canadian Institutes of Health Research (CIHR) Vanier Canada Graduate Scholarship and a CIHR Strategic Training Fellowship in Work Disability Prevention. Carnide was previously a post-doctoral fellow at the Institute.
Carnide's research interests lie at the intersection between occupational health and safety and pharmaco-epidemiology. They include substance use and mental health problems among working populations. Her research projects have involved analysis of survey and administrative data, as well as systematic reviews. Her doctoral dissertation focused on the use of prescription opioids among workers with work-related low-back pain and their association with work disability. Her emerging program of research builds on this work to examine the use and non-medical use of prescription and recreational central nervous system drugs (including opioids and cannabis) among workers, their risk factors and the workplace consequences of their use, with a current focus on the impact of cannabis legalization.
“The gaps in knowledge around the scope, determinants and effects of substance use among workers are vast. Given the current opioid crisis and the move towards cannabis legalization in multiple jurisdictions, including Canada, I cannot think of a more timely area for research in occupational health and safety.” – Dr. Nancy Carnide
Research areas
Projects
- Cannabis and workplace fatalities: establishing a baseline in Ontario. Funded by Canadian Institutes of Health Research. Ongoing. (PI on the project)
- Workplace cannabis use and perceptions among Canadian workers. Funded by Canadian Institutes of Health Research. Ongoing. (PI on the project)
- Central nervous system agents and the risk of workplace injury and death: a systematic review. Funded by WorkSafeBC. Completed. (PI on the project)
- Strategies to support the appropriate use of prescription opioids: a systematic review. Funded by Canadian Institutes of Health Research . Completed.
- Understanding the use and impact of early opioid prescriptions for work-related low-back pain. Funded by Canadian Institutes of Health Research, WorkSafeBC. Completed.
Publications
- Carnide N, Hogg-Johnson S, Cote P, Koehoorn M, Furlan AD. Factors associated with early opioid dispensing compared with NSAID and muscle relaxant dispensing after a work-related low back injury. Occupational and Environmental Medicine. 2020 [epub ahead of print]. doi:10.1136/oemed-2019-106380.
- Orchard C, Carnide N, Smith PM. How does perceived fairness in the workers' compensation claims process affect mental health following a workplace injury?. Journal of Occupational Rehabilitation. 2020;30(1):40-48. doi:10.1007/s10926-019-09844-3.
- Orchard C, Carnide N, Mustard C, Smith PM. Prevalence of serious mental illness and mental health service use after a workplace injury: a longitudinal study of workers' compensation claimants in Victoria, Australia. Occupational and Environmental Medicine. 2020;77(3):185-187. doi:10.1136/oemed-2019-105995.
- Carnide N, Hogg-Johnson S, Koehoorn M, Furlan AD, Cote P. Relationship between early prescription dispensing patterns and work disability in a cohort of low back pain workers' compensation claimants: a historical cohort study. Occupational and Environmental Medicine. 2019;76(8):573-581. doi:10.1136/oemed-2018-105626.
- Carnide N, Hogg-Johnson S, Furlan AD, Cote P, Koehoorn M. Prescription dispensing patterns before and after a workers' compensation claim: an historical cohort study of workers with low back pain injuries in British Columbia. Journal of Occupational and Environmental Medicine. 2018;60(7):644-655. doi:10.1097/JOM.0000000000001311.
Speaker Series presentations
- Have cannabis use and perceptions about workplace use changed since legalization?. IWH Speaker Series. March 3, 2020.
- The link between workplace injury and fatality risks and the use of substances affecting the central nervous system. IWH Speaker Series. May 28, 2019.
- Clearing the haze: Understanding how Canadian workers use and perceive cannabis at work. IWH Speaker Series. November 20, 2018.
Interviews and articles
- At-work use of cannabis reported by 1 in 12 workers—no change since legalization. At Work: Institute for Work & Health; No. 100, Spring 2020.
- Where does the use of cannabis now stand in the eyes of the workplace?. Daily Commercial News. March 18, 2020. Available from: https://canada.constructconnect.com/dcn/news/ohs/2020/03/where-does-the-use-of-cannabis-now-stand-in-the-eyes-of-the-workplace
- Addressing mental health, substance abuse at work requires new approaches: Experts. Daily Commercial News. March 16, 2020. Available from: https://canada.constructconnect.com/dcn/news/associations/2020/03/addressing-mental-health-substance-abuse-at-work-requires-new-approaches-experts
- IWH takes deep dive into the marijuana Pandora’s box. Daily Commercial News. January 31, 2020. Available from: https://canada.constructconnect.com/dcn/news/ohs/2020/01/iwh-takes-deep-dive-into-the-marijuana-pandoras-box
- Grant round-up: Anticipating future risks among externally funded projects under way at IWH. At Work: Institute for Work & Health; No. 99, Winter 2020.